| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 05/11/2006 | US20060100227 Pyrimidine derivaties |
| 05/11/2006 | US20060100225 Heteroaryl guanidines; inhibitors of viral replication |
| 05/11/2006 | US20060100223 Quinazoline derivatives and pharmaceutical compositions containing them |
| 05/11/2006 | US20060100219 Dihydroimidazoles and tetrahydropyrmidines containing amide and sulfonamide groups, e.g., 3-[(2,3-Dichlorobenzenesulphonyl)methylamino]-N-{2-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]ethyl}-N-methylpropionamide; treating pain, skin disease, irritable bladder or colon, asthma, COPD, and stomach inflammation |
| 05/11/2006 | US20060100217 Preparation of 4-haloalkylnicotinamides |
| 05/11/2006 | US20060100211 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/11/2006 | DE4338348B4 2,6-Disubstituierte Benzotrifluoride 2,6-Disubstituted benzotrifluorides |
| 05/11/2006 | CA2586602A1 Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives |
| 05/11/2006 | CA2586073A1 Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
| 05/11/2006 | CA2585539A1 Process for the production of pyrimidine-5-carboxylates |
| 05/11/2006 | CA2585210A1 Pyrimidine and quinoline potentiators of metabotropic glutamate receptors |
| 05/10/2006 | EP1655289A1 Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives |
| 05/10/2006 | EP1655288A1 Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
| 05/10/2006 | EP1654251A1 Chemical compounds |
| 05/10/2006 | EP1654249A1 Anthelmintic and insecticide pyrimidine derivatives |
| 05/10/2006 | EP1654238A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 05/10/2006 | EP1654237A1 2-aminopyrimidine derivatives |
| 05/10/2006 | EP1654232A1 Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides |
| 05/10/2006 | EP1536799B1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properties |
| 05/10/2006 | EP1495006A4 Inhibitors of glycinamide ribonucleotide transformylase |
| 05/10/2006 | CN1771229A Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto-esters |
| 05/10/2006 | CN1769285A Doxazosin salt with optical activity |
| 05/10/2006 | CN1255388C Process for preparing 4,6-dichloropyrimidine |
| 05/10/2006 | CN1255387C Pyrimidine derivatives useful as selective COX-2 inhibitors |
| 05/09/2006 | US7041673 Ultrashort acting hypnotic barbiturates |
| 05/09/2006 | US7041670 Florfenicol-type antibiotics |
| 05/09/2006 | US7041235 Fluorescent diketopyrrolopyrrole analogues |
| 05/04/2006 | WO2006046916A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | WO2006046691A1 Process for production of 4-aminopyrimidines |
| 05/04/2006 | WO2006046593A1 Benzene compound having 2 or more substituents |
| 05/04/2006 | WO2006046131A1 Tetralin histamine-3 receptor antagonists |
| 05/04/2006 | WO2006045612A1 Process for the preparation of phenyl 2-pyrimidinyl ketones and their novel intermediates |
| 05/04/2006 | WO2006021454A3 Pyrimidine derivatives |
| 05/04/2006 | WO2005112938A3 Disalt inhibitors of il-12 production |
| 05/04/2006 | WO2005070901A3 Pyrimidyl phosphonate antiviral compounds and methods of use |
| 05/04/2006 | WO2005025681A3 A system for and a method of manufacturing personal golf putters |
| 05/04/2006 | US20060094789 Alpha- and beta-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 05/04/2006 | US20060094737 Novel uracil derivatives and medicinal use thereof |
| 05/04/2006 | US20060094012 Polymorphisms for predicting disease and treatment outcome |
| 05/04/2006 | CA2584413A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/03/2006 | EP1651620A2 Piperazine derivatives and their use as therapeutic agents |
| 05/03/2006 | EP1651619A1 Substituted pyrimidin-4-ylamin analogues as vanilloid receptor ligands |
| 05/03/2006 | EP1651618A1 2-substituted pyrimidines |
| 05/03/2006 | EP1651617A1 2-substituted pyrimidines |
| 05/03/2006 | EP1651611A2 Benzimidazole c-2 heterocycles as kinase inhibitors |
| 05/03/2006 | EP1651595A2 Ubiquitin ligase inhibitors |
| 05/03/2006 | EP1651229A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 05/03/2006 | EP1562902B1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/03/2006 | EP1390351B1 Pyrimidine derivatives useful as selective cox-2 inhibitors |
| 05/03/2006 | EP1099692B1 N,n-substituted cyclic amine derivatives |
| 05/03/2006 | EP0672042B1 Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
| 05/03/2006 | CN1768059A Pyrido [2,3-d] pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents |
| 05/03/2006 | CN1768045A 2-substituted pyrimidines |
| 05/03/2006 | CN1765895A Nolatrexed hydrochloride synthesis process |
| 05/02/2006 | US7038049 Anticancer agents; antitumor agents; apoptosis of breast tumor cells; drug resistance leukemia |
| 05/02/2006 | US7037927 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 05/02/2006 | US7037918 Antidiabetic agents, cardiovascular disorders, Alzheimer's disease, nervous system disorders |
| 05/02/2006 | US7037917 Nitrogen compounds such as 4-((4-amino-5-bromo-6-(4-cyano-2,6-dimethylphenyloxy)-2 -pyrimidinyl)amino)benzonitrile, used as protease inhibitors for prophylaxis of viral diseases |
| 05/02/2006 | US7037916 Antiinflammatory agents; antiarthritic agents; anticholesterol agents; cardiovascular disorders; muscle and skin disorders |
| 05/02/2006 | US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease |
| 05/02/2006 | US7037908 HIV integrase inhibitors |
| 05/02/2006 | CA2149147C Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
| 04/27/2006 | WO2006044823A2 Heteroaryl-substituted alkyne compounds and method of use |
| 04/27/2006 | WO2006044732A2 2, 6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists |
| 04/27/2006 | WO2006044457A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 04/27/2006 | WO2006043515A1 Pyrimidine-5-carboxylic acid derivative |
| 04/27/2006 | WO2006043490A1 Pyrimidine derivative fused with nonaromatic ring |
| 04/27/2006 | WO2006015382A3 Integrin alpha-v beta-3 antagonists for use in imaging and therapy |
| 04/27/2006 | WO2006000371A3 Pyrimidine derivatives as 11beta-hsd1 inhibitors |
| 04/27/2006 | US20060089501 Reacting 4-(Fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)-5-hydroxymethyl-pyrimidine (FPP OH) with 2,2,6,6-tetramethylpiperidine-1-oxyl (Tempo) in the presence of a co-oxidant to form 4-(Fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)-5-formyl-pyrimidine (FPP CHO) intermediate |
| 04/27/2006 | US20060089500 Beta-aryl-alpha-oxysubstituted alkylcarboxylic acids; antiobesity and hypocholesterolemic compounds |
| 04/27/2006 | US20060089371 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| 04/27/2006 | US20060089369 pyrimidine and pyridine derivatives; diabetes, neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency, cancer |
| 04/27/2006 | US20060089354 ligands for receptor localization studies; for inhibiting binding of vanilloid ligand to a capsaicin receptor; Phosphoric acid dibenzyl ester 4-(4-tert-butyl-phenylamino)-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-2-ylmethyl ester; to treat neuropathic pain, itch, urinary incontinence, cough, obesity |
| 04/27/2006 | US20060089262 Substituted (thioxo)carbonylamino phenyl uraciles |
| 04/27/2006 | DE19741739B4 Supramolekulares Paarungssystem, dessen Herstellung und Verwendung Supramolecular mating system, its preparation and use |
| 04/27/2006 | CA2580913A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 04/26/2006 | EP1650196A1 Process for producing 6,7-bis(2-methoxyethoxy)-quinazolin-4-one |
| 04/26/2006 | EP1648877A1 Substituted pyridin-2-ylamine analogues |
| 04/26/2006 | EP1648876A1 5-ht sb 2b /sb receptor antagonists |
| 04/26/2006 | EP1648875A1 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| 04/26/2006 | EP1648856A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 04/26/2006 | EP1648464A1 2-amino-4-hydroxy-5-pyrimidincarboxamid derivatives and related compounds as t-cell activation inhibitors for the treatment of inflammations |
| 04/26/2006 | EP1244454B1 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions |
| 04/26/2006 | CN1764651A Quinazoline derivatives as antitumor agents |
| 04/26/2006 | CN1764650A 2, 3, 6-trisubstituted-4-pyrimidone derivatives |
| 04/26/2006 | CN1764623A Process for producing tetraalkoxypropane and derivative thereof |
| 04/26/2006 | CN1764454A Cyclic protein tyrosine kinase inhibitors |
| 04/26/2006 | CN1763016A Preparation of aminopyrimidine compounds. |
| 04/26/2006 | CN1763015A Preparation method and intermediate of rosuvastatin and its pharmaceutical salts |
| 04/25/2006 | US7034156 Method for the production of 1-amino-3-phenyluracil derivatives |
| 04/25/2006 | US7034153 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/25/2006 | US7034131 Antibody therapy; immobilization |
| 04/25/2006 | US7034047 Triazole derivative |
| 04/25/2006 | US7034046 NR1H4 nuclear receptor binding compounds |
| 04/25/2006 | US7034035 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 04/25/2006 | US7034033 Substituted quinazolinone compounds |
| 04/25/2006 | US7034019 Prodrugs of HIV replication inhibiting pyrimidines |
| 04/25/2006 | US7034014 Phosphonate compounds |